Ana Jaklenec

Dr. Ana Jaklenec is a Principal Investigator at the Koch Institute for Integrative Cancer Research at MIT. With over 20 years of experience, she’s a leader in the fields of bioengineering and materials science, focused on manufacturing controlled delivery systems and stabilizing therapeutics for global health. She is an inventor of several drug delivery technologies that have the potential to enable access to medical care globally, has published over 160 manuscripts, patents and patent applications and has founded three companies, Particles for Humanity, VitaKey, and OmniPulse Biosciences. Dr. Jaklenec received a B.S. in Biomedical Engineering from Boston University and a Ph.D. in Biomedical Engineering from Brown University. Her postdoctoral training was with Institute Prof. Robert Langer at MIT, where her research focused on drug delivery of biologics (among other projects). Jaklenec was elected to the National Academy of Inventors (NAI) Class of Fellows, the highest professional dis